Research Journal of Pharmacy and Technology

SCOPUS
  • Year: 2019
  • Volume: 12
  • Issue: 9

New Validated Stability-Indicating RP-HPLC Method for The Determination of Docetaxel and Its Related Substances

  • Author:
  • S. Hemchand1,, R. Ravi Chandra Babu1, Mukthinuthalapati Mathrusri Annapurna2
  • Total Page Count: 17
  • Page Number: 4165 to 4181

1GITAM Institute of Science, GITAM (Deemed to be University), Visakhapatnam, India

2GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India

Abstract

Docetaxel is used for the treatment of castration resistant prostate cancer. Docetaxel is a semi synthetic chemo therapeutic agent extracted from the leaves of Taxus baccata. Two process related substances and four impurities were separated and quantified using Sunfire C18 column (250 x 4.6 mm, 5μm particle size) on gradient mode (40 ± 5°C). A mixture of acetonitrile: 0.01% Acetic acid was used as mobile phase and a mixture of acetonitrile: methanol (1:1, v/v) was used as diluent and the compounds were monitored at 230 nm. Forced degradation studies were performed and the method was validated as per ICH guidelines.

Keywords

Docetaxel, RP-HPLC, Related substances, Gradient mode, Impurities, Stability indicating